within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AP07_Daclatasvir;
model Daclatasvir 
   extends Pharmacolibrary.Drugs.ATC.J.J05AP07;

  annotation(Documentation(
    info ="<html><body><p>Daclatasvir is a direct-acting antiviral medication that acts as an inhibitor of the HCV NS5A protein, thereby inhibiting hepatitis C virus (HCV) replication. It is approved for use, often in combination with other antivirals, for the treatment of chronic HCV infection in adults.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in healthy adult subjects (sex not specified) after single oral dose.</p><h4>References</h4><ol><li><p>Elbadawy, HA, et al., &amp; El-Demerdash, E (2022). Effect of Atorvastatin on Single Oral Pharmacokinetics and Safety of Daclatasvir in Rats: Emphasis on P-glycoprotein and Cytochrome P450. <i>Current drug metabolism</i> 23(6) 484–495. DOI:<a href=&quot;https://doi.org/10.2174/1389200223666220404134524&quot;>10.2174/1389200223666220404134524</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35379125/&quot;>https://pubmed.ncbi.nlm.nih.gov/35379125</a></p></li><li><p>Gandhi, Y, et al., &amp; Garimella, T (2018). Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics. <i>Clinical pharmacokinetics</i> 57(8) 911–928. DOI:<a href=&quot;https://doi.org/10.1007/s40262-017-0624-3&quot;>10.1007/s40262-017-0624-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29353349/&quot;>https://pubmed.ncbi.nlm.nih.gov/29353349</a></p></li><li><p>Dogra, A, et al., &amp; Nandi, U (2018). Intervention of curcumin on oral pharmacokinetics of daclatasvir in rat: A possible risk for long-term use. <i>Phytotherapy research : PTR</i> 32(10) 1967–1974. DOI:<a href=&quot;https://doi.org/10.1002/ptr.6123&quot;>10.1002/ptr.6123</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29806225/&quot;>https://pubmed.ncbi.nlm.nih.gov/29806225</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Daclatasvir;
